Bandaríkin - enska - NLM (National Library of Medicine)

lantheus medical imaging, inc. - bicisate dihydrochloride (unii: b005p07v07) (bicisate - unii:3jxf0z0xoi) - bicisate dihydrochloride 0.9 mg - neurolite single photon emission computerized tomography (spect) is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed. neurolite is not indicated for assessment of functional viability of brain tissue. also, neurolite is not indicated for distinguishing between stroke and other brain lesions. none known.

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

euro-pharm international canada inc., canada - oral drops, solution - 400 iu - vitamin d3 (cholecalciferol)

Írland - enska - HPRA (Health Products Regulatory Authority)

pliva pharma limited - polymyxin b sulfate ; bacitracin zinc - unknown - international unit - bacitracin

Bandaríkin - enska - NLM (National Library of Medicine)

novocol pharmaceutical of canada, inc - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j), levonordefrin (unii: v008l6478d) (levonordefrin - unii:v008l6478d) - mepivacaine hydrochloride 20 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. scandonest® is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

Bandaríkin - enska - NLM (National Library of Medicine)

moberg pharma north america llc - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide .113 g in 1 g - - helps treat and prevent diaper rash - protects chafed skin due to diaper rash and helps seal out wetness

Bandaríkin - enska - NLM (National Library of Medicine)

moberg pharma north america llc - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide .113 g in 1 g - - helps relieve and prevent rashes and irritation due to wetness from incontinence - protects chafed skin due to irritation and helps seal out wetness

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - doxycycline hyclate, quantity: 116.3 mg (equivalent: doxycycline, qty 100 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; purified water; hypromellose phthalate; hyprolose; wheat starch; diethyl phthalate; hypromellose; gelatin; povidone; ethanol; shellac; pharmaceutical glaze; carbon black - indications as at 24 march 2004: doxycycline is primarily bacteriostatic and is thought to exert its antimicrobial effect by the inhibition of protein synthesis. doxycycline is active against a wide range of gram positive and gram negative organisms. note: the 50 mg capsule is not a paediatric formulation. doryx is indicated in the treatment of infections caused by the following micro-organisms: mycoplasma pneumoniae: primary atypical pneumonia. rickettsiae: queensland tick typhus, typhus fever and q fever agents of psittacosis. calymmatobacterium (donovania) granulomitis: granuloma inguinale. agents of lymphogranuloma venereum. borreliae: relapsing fever. chlamydia trachomatis. doryx is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doryx alone, or in combination with topical agents. doryx is indicated in the treatment of infections caused by the following gram negative micro-or

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - doxycycline hyclate, quantity: 58.15 mg (equivalent: doxycycline, qty 50 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; hypromellose; gelatin; diethyl phthalate; hypromellose phthalate; lactose monohydrate; purified water; wheat starch; hyprolose; ethanol; shellac; pharmaceutical glaze; carbon black - indications as at 24 march 2004: doxycycline is primarily bacteriostatic and is thought to exert its antimicrobial effect by the inhibition of protein synthesis. doxycycline is active against a wide range of gram positive and gram negative organisms. note: the 50 mg capsule is not a paediatric formulation. doryx is indicated in the treatment of infections caused by the following micro-organisms: mycoplasma pneumoniae: primary atypical pneumonia. rickettsiae: queensland tick typhus, typhus fever and q fever agents of psittacosis. calymmatobacterium (donovania) granulomitis: granuloma inguinale. agents of lymphogranuloma venereum. borreliae: relapsing fever. chlamydia trachomatis. doryx is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doryx alone, or in combination with topical agents. doryx is indicated in the treatment of infections caused by the following gram negative micro-or

Kanada - enska - Health Canada

pharmaceutical partners of canada inc - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride); selenium (selenious acid); iodide (sodium iodide) - solution - 5mg; 1mg; 0.5mg; 10mcg; 60mcg; 75mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg; selenium (selenious acid) 60mcg; iodide (sodium iodide) 75mcg - replacement preparations

Kanada - enska - Health Canada

pharmaceutical partners of canada inc - zinc (zinc sulfate); copper (cupric sulfate); manganese (manganese sulfate); chromium (chromic chloride) - solution - 5mg; 1mg; 0.5mg; 10mcg - zinc (zinc sulfate) 5mg; copper (cupric sulfate) 1mg; manganese (manganese sulfate) 0.5mg; chromium (chromic chloride) 10mcg - replacement preparations